Bioterrorism-Related Webcasts from the Third International Conference on Emerging Infectious Diseases (ICEID 2002)

Webcasts by CDC Presenters

• An Anthrax Outbreak Averted: Public Health Response to a Contaminated Envelope on Capitol Hill, Washington, DC, 2001
  Vincent Hsu, CDC, Atlanta, GA
  March 26, 2002
• Anthrax in the US Postal System
  Michele Pearson, CDC, Maryland
  March 26, 2002
• Bioterrorism Preparedness: Lessons, Challenges, and Opportunities
  James Hughes, CDC, Atlanta, GA
  March 25, 2002
• Importance of Bacillus anthracis Molecular Subtyping During the Recent Multi-State Bioterrorism-Associated Anthrax Outbreak in the United States
  Alex Hoffmaster, CDC, Atlanta, GA
  March 26, 2002
• Inhalational Anthrax—New York City, October–November 2001
  Timothy Holtz, CDC and New York City Department of Health, New York, NY
  March 26, 2002
• Letters from Trenton: The Anthrax Investigation at the Source, New Jersey, 2001
  Jennita Reefhuis, CDC, Atlanta, GA
  March 26, 2002
• Rapid Adaptation of a Serologic Assay for the Bioterrorism-Related Anthrax Outbreak—October–December, 2001
  Carolyn Greene, CDC, Atlanta, GA
  March 26, 2002
• Smallpox Vaccine and Vaccination Strategies
  Joanne Cono, CDC, Atlanta, GA
  March 25, 2002
• Virology and Diagnosis of Smallpox
  Russell Regnery, CDC, Atlanta, GA
  March 25, 2002

Webcasts by Non-CDC Presenters

Note: the views expressed by non-CDC presenters do not necessarily represent the views of CDC. Links to these webcasts are provided solely as a service to our users. These links do not indicate an endorsement of the presenters, their organizations, or any commercial products by CDC.

• Anthrax Vaccines
  Arthur Friedlander, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD
  March 27, 2002
• Bioterrorism [Public Health Policy/Law]
  Richard Hoffman, Colorado Department of Public Health and Environment, Denver, CO
  March 25, 2002
• Bioterrorism 2001: Lessons Learned
  Leonard Cole, Department of Political Science, Rutgers University, Newark, NJ
  March 26, 2002
• BT Surveillance in NYC
  Farzad Mostashari, Bureau of Communicable Disease, New York City Department of Health, New York, NY
  March 25, 2002
• Clinical and Epidemiologic Features of Smallpox
  Stanley Foster, Rollins School of Public Health, Emory University, Atlanta, GA
  March 25, 2002
• Clinical Management of Smallpox Patients
  Peter L. Havens, Medical College of Wisconsin, Milwaukee, WI
  March 25, 2002
• Cutaneous Anthrax in New York City
  Marcelle Layton, New York Department of Health, New York, NY
  March 26, 2002
• Enhanced Emergency Department Surveillance System Following the World Trade Disaster—New York City, September 14 to October 10, 2001
  Debjani Das, New York Department of Health, New York, NY
  March 25, 2002
• Inhalation Anthrax in Florida
  Steve Wiersma, Florida Department of Health, Tallahassee, FL
  March 26, 2002
• Inhalation Anthrax of Unknown Source
  James Hadler, Connecticut Department of Public Health, Hartford, CT
  March 26, 2002
• Laboratory Response in the Commonwealth of Virginia to the Intentional Release of Bacillus anthracis
  Denise Pettit, Division of Consolidated Laboratory Services, Richmond, VA
  March 25, 2002
• Public Health Laboratory Response to an Anthrax Incident in Connecticut
  Donald Mayo, Connecticut State Health Department, Hartford, CT
  March 25, 2002
• Rapid Molecular Identification of B. anthracis in New York State in Response to Recent Bioterrorism Incidents
  Kimberlee Musser, New York, State Department of Health, Albany, NY
  March 25, 2002
• Surveillance of Livestock for Zoonotic Diseases and Veterinary Bio-Threat Agents
  William Hueston, College of Veterinary Medicine, University of Minnesota, St. Paul, MN
  March 25, 2002
• The Role of Healthcare Systems in Bioterrorism Preparedness
  Trish Perl, Johns Hopkins Hospital, Baltimore, MD
  March 26, 2002
• Threat Letter Menace: The Fiji Experience
  Kamal Kishore, Fiji School of Medicine, Suva, Fiji
  March 25, 2002